Statistics

Total Visits

Views
Open label phase II clinical trial of orteronel (TAK700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The Greko II study-GETHI 20130140

Select a period of time:

Number of views in the range

Views
Open label phase II clinical trial of orteronel (TAK700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The Greko II study-GETHI 20130126

Views

Views
October 20242
November 20241
December 20241
January 20253
February 20253
March 202516
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States10
United Kingdom1
 

Top cities views

Views